IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of the Rad-G™ Pulse Oximeter, a rugged handheld device that provides clinically proven SET ® pulse oximetry, ...
Masimo recently announced the recall of some of its Rad-G pulse oximeters after reports of unintended change of device power state. Nabbing FDA clearance in September 2020, Rad-G is a portable SET ...
New Study Assesses the Effects of Masimo Patient SafetyNet™ on Nursing Workflows in the General Ward
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of PeriAnesthesia Nursing in which Drs. Mashasi Ishikawa and Atsuhiro ...
Masimo Corporation MASI received FDA approval for the domestic use of Rad-97 Pulse CO-Oximeter. This product will offer non-invasive and continuous monitoring. The product comprises Measure-through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results